High Point Advisor Group LLC Sage Therapeutics, Inc. Transaction History

High Point Advisor Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $157,980 - $225,119	-3,924 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$54.88 - $79.29 $19,647 - $28,385	358 Added 10.04%	3,924 $223,000
Q1 2021 Apr 12, 2021	BUY	$70.65 - $96.76 $21,195 - $29,028	300 Added 9.19%	3,566 $273,000
Q4 2020 Feb 10, 2021	BUY	$58.41 - $89.06 $190,767 - $290,869	3,266 New	3,266 $271,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.